Inovio Pharmaceuticals, Inc. (INO)
1.25
+0.07
(+5.93%)
USD |
NASDAQ |
Aug 24, 16:00
1.23
-0.02
(-1.60%)
After-Hours: 20:00
Inovio Pharmaceuticals Total Liabilities (Quarterly) : 45.02M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.02M |
| March 31, 2026 | 43.71M |
| December 31, 2025 | 51.59M |
| September 30, 2025 | 77.11M |
| June 30, 2025 | 39.71M |
| March 31, 2025 | 36.02M |
| December 31, 2024 | 46.40M |
| September 30, 2024 | 33.52M |
| June 30, 2024 | 37.06M |
| March 31, 2024 | 34.67M |
| December 31, 2023 | 55.60M |
| September 30, 2023 | 54.94M |
| June 30, 2023 | 63.67M |
| March 31, 2023 | 67.37M |
| December 31, 2022 | 128.49M |
| September 30, 2022 | 125.27M |
| June 30, 2022 | 161.73M |
| March 31, 2022 | 90.43M |
| December 31, 2021 | 99.24M |
| September 30, 2021 | 82.15M |
| June 30, 2021 | 83.25M |
| March 31, 2021 | 73.22M |
| December 31, 2020 | 82.37M |
| September 30, 2020 | 113.81M |
| June 30, 2020 | 256.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 151.07M |
| December 31, 2019 | 146.48M |
| September 30, 2019 | 115.41M |
| June 30, 2019 | 108.60M |
| March 31, 2019 | 110.20M |
| December 31, 2018 | 44.08M |
| September 30, 2018 | 36.99M |
| June 30, 2018 | 37.43M |
| March 31, 2018 | 60.57M |
| December 31, 2017 | 44.75M |
| September 30, 2017 | 41.56M |
| June 30, 2017 | 35.32M |
| March 31, 2017 | 47.37M |
| December 31, 2016 | 50.33M |
| September 30, 2016 | 47.57M |
| June 30, 2016 | 41.90M |
| March 31, 2016 | 40.07M |
| December 31, 2015 | 37.91M |
| September 30, 2015 | 37.39M |
| June 30, 2015 | 20.75M |
| March 31, 2015 | 14.43M |
| December 31, 2014 | 20.25M |
| September 30, 2014 | 17.49M |
| June 30, 2014 | 19.88M |
| March 31, 2014 | 22.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Fortress Biotech, Inc. | 110.63M |
| Tonix Pharmaceuticals Holding Corp. | 31.81M |
| Kura Oncology, Inc. | 539.36M |
| Spero Therapeutics, Inc. | 8.562M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 49.39M |
| Shareholders Equity (Quarterly) | 4.371M |
| Debt to Equity Ratio | 1.831 |
| Current Ratio | 1.00 |
| Net Debt Paydown Yield | 0.72% |